NASDAQ:IBB   ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND
99 1 3
Crab nearly completed. Candlestick makes me question if it will achieve target.
One thing I noticed about the IBB is that it corrected 10% unlike the overall market did. Short float is also 33%. GILD is also the heaviest weighted company within the IBB and it is trading very cheap to it's peers due to concern that profits may be limited to their current pipeline. If they acquire another company, which they probably will, GILD will soar taking IBB with it (Kind of like CELG did). I know this is a focus on technicals but may be something to consider :)
Reply
United States
United Kingdom
India
España
France
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out